FDA clears tests of Durham startup Grid Therapeutics’ cancer immunotherapy
Grid Therapeutics has received clearance from the U.S. Food and Drug Administration to begin human testing of its new cancer immunotherapy.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
